The role of His-18 in amyloid formation by human islet amyloid polypeptide

Biochemistry

Volumn 44, Issue 49, 2005, Pages 16284-16291

  Abedini, Andisheh ^a   Raleigh, Daniel P ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MEMBRANES; ENZYMES; HISTOLOGY; MONOMERS; MORPHOLOGY; PH EFFECTS;

DIABETES; FIBRIL FORMATION; PROTONATION;

POLYPEPTIDES;

AMYLIN; HISTIDINE; SYNTHETIC PEPTIDE; THIOFLAVINE;

AMYLOIDOSIS; ARTICLE; BINDING KINETICS; CIRCULAR DICHROISM; HUMAN; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; TRANSMISSION ELECTRON MICROSCOPY;

AMINO ACID SEQUENCE; AMYLOID; HISTIDINE; HUMANS; HYDROGEN-ION CONCENTRATION; MOLECULAR SEQUENCE DATA; SEQUENCE ALIGNMENT; THIAZOLES;

EID: 28944446580     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi051432v     Document Type: Article

References (34)

1. Zimmet, P., Alberti, K. G. M. M., and Shaw, J. (2001) Global and societal implications of the diabetes epidemic, Nature 414, 782-787.
2. Kudva, Y. C., and Butler, P. C. (1997) Insulin secretion in type-2 diabetes mellitus, In Clinical Research in Diabetes and Obesity, Vol. 2, Diabetes and Obesity, Humana Press, Totowa, NJ.
3. DeFronzo, R. A. (1988) Lilly Lecture 1987: The triumvirate: Cell, muscle, liver: A collusion responsible for NIDDM, Diabetes 37, 667-687.
4. Rocken, C., Linke, R. P., and Saeger, W. (1992) Immunohistology of islet amyloid polypeptide in diabetes mellitus: Semiquantitative studies in a post-mortem series, Virchows Arch. A Pathol. Anat. Histopathol. 421, 339-344.
5. Schneider, H. M., Storkel, S., and Will, W. (1980) Das Amyloid der Langerhansschen Inseln und seine Beziehung zum Diabetes mellitus, Dtsch. Med. Wochenschr. 105, 1143-1147.
6. Kahn, S. E., Andrikopoulos, S., and Verchere, C. B. (1999) Islet amyloid: A long-recognied but underappreciated pathological feature of type 2 diabetes, Diabetes 48, 241-253.
7. Clark, A., Wells, C. A., Buley, I. D., Cruickshank, J. K., Vanhegan, R. I., Matthews, D. R., Cooper, G. J., Holman, R. R., and Turner, R. C. (1988) Islet amyloid, increased A-cells, reduced B-cells, and exocrine fibrosis: Quantitative changes in the pancreas in type 2 diabetes, Diabetes Res. Clin. Pract. 9, 151-159.
8. Lorenzo, A., Razzaboni, B., Weir, G., and Yankner, B. (1994) Pancreatic islet cell toxicity of amylin associated with type 2 diabetes mellitus, Nature 368, 756-760.
9. Schubert, D., Behl, C., Lesley, R., Brack, A., Dargusch, R., Sagara, Y., and Kimura, H. (1995) Amyloid peptides are toxic via a common oxidative mechanism, Proc. Natl. Acad. Sci. U.S.A. 92, 1989-1993.
10. Westermark, P., Wernstedt, C., Wilander, E., Hayden, D. W., O'Brien, T. D., and Johnson, K. H. (1987) Amyloid fibrils in human insulinoma and islets of langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells, Proc. Natl. Acad. Sci. U.S.A. 84, 3881-3885.
11. Cooper, G. J. S., Willis, A. C., Clark, A., Turner, R. C., Sim, R. B., and Reid, K. B. M. (1987) Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients, Proc. Natl. Acad. Sci. U.S.A. 84, 8628-8632.
12. Kahn, S. E., D'Alessio, D. A., Schwartz, M. W., Fujimoto, W. Y., Ensinck, J. W., Taborsky, G. J. J., and Porte, D. J. (1990) Evidence of cosecretion of islet amyloid polypeptide and insulin by β-cells, Diabetes 39, 634-638.
13. Sanke, T., T., H., Nakano, Y., Oki, C., Okai, K., Nishimura, S., Kondo, M., and Nanjo, K. (1991) Plasma islet amyloid polypeptide (amylin) levels and their responses to oral glucose in type 2 (non-insulin-dependent) diabetic patients, Diabetologia 34, 129-132.
14. Butler, P. C., Chou, J., Carter, W. B., Wang, Y. N., Bu, B. H., Chang, D., Chang, J. K., and Rizza, R. A. (1990) Effects of meal ingestion on plasma amylin concentration in NIDDM and non-diabetic humans, Diabetes 39, 752-756.
15. Hutton, J. C. (1989) The insulin secretory granule, Diabetologia 32, 271-281.
16. Gebre-Medhin, S., Mulder, H., Pekny, M., Westermark, G., Tornell, J., Westermark, P., Sundler, F., Ahren, B., and Betsholtz, C. (1998) Increased insulin secretion and glucose tolerance in mice lacking islet amyloid polypeptide (amylin), Biochem. Biophys. Res. Commun. 250, 271-277.
17. Ahren, B., Oosterwijk, C., Lips, C. J., and Hoppener, J. W. (1998) Transgenic overexpression of human islet amyloid polypeptide inhibits insulin secretion and glucose elimination after gastric glucose gavage in mice, Diabetologia 41, 1374-1380.
18. Goldsbury, C., Cooper, G. J. S., Goldie, K. N., Muller, S. A., Saafi, E. L., Gruijters, W. T. M., Misur, M. P., Engel, A., Aebi, U., and Kistler, J. (1997) Polymorphic fibrillar assembly of human amylin, J. Struct. Biol. 119, 17-27.
19. Goldsbury, C. S., Kistler, J., Aebi, U., Arvinte, T., and Cooper, G. J. S. (1999) Watching amyloid fibrils grow by time-lapse atomic force microscopy, J. Mol. Biol. 285, 33-39.
20. Goldsbury, C., Goldie, K., Pellaud, J., Seelig, J., Frey, P., Muller, S. A., Kistler, J., Cooper, G. J. S., and Aebi, U. (2000) Amyloid fibril formation from full-length and fragments of amylin, J. Struct. Biol. 130, 352-362.
21. Tracz, S. M., Abedini, A., Driscoll, M., and Raleigh, D. P. (2004) The role of aromatic interactions in amyloid formation by polypeptides: Analysis of peptides derived from human amylin, Biochemistry 43, 15901-15908.
22. Fraser, P. E., McLachlan, D. R., Surewicz, W. K., Mizzen, C. A., Snow, A. D., Nguyen, J. T., and Kirschner, D. A. (1994) Conformation and fibrillogenesis of Alzheimer Aβ peptides with selected substitution of charged residues, J. Mol. Biol. 244, 64-73.
23. Emdin, S. O., Dobson, G. G., Cutfield, J. M., and Cutfield, S. M. (1980) Role of zinc in insulin biosynthesis. Some possible zinc-insulin interactions in the pancreatic cell, Diabetologia 19, 174-182.
24. Charge, S. B. P., de Koning, E. J. P., and Clark, A. (1995) Effect of pH and insulin on fibrillogenesis of islet amyloid polypeptide in vitro, Biochemistry 34, 14588-14593.
25. LeVine, H. (1993) Thioflavin-T interaction with synthetic Alzheimer's disease β-amyloid peptides: Detection of amyloid aggregation in solution, Protein Sci. 2, 404-410.
26. Kudva, Y. C., Mueske, C., Butler, P. C., and Eberhardt, N. L. (1998) A novel assay in vitro of human islet amyloid polypeptide amyloidogenesis and effects of insulin secretory vesicle peptides on amyloid formation, Biochem. J. 331, 809-813.
27. Cannon, M. J., Williams, A. D., Wetzel, R., and Myszka, D. G. (2004) Kinetic analysis of β-amyloid fibril elongation, Anal. Biochem. 328, 67-75.
28. Jaikaran, E. T. A. S., Higham, C. E., Serpell, L. C., Zurdo, J., Gross, M., Clark, A., and Fraser, P. E. (2001) Identification of a novel human islet amyloid polypeptide β-sheet domain and factors influencing fibrillogenesis, J. Mol. Biol. 308, 515-525.
29. Kajava, A. V., Aebi, U., and Steven, A. C. (2005) The parallel superpleated β-structure as a model for amyloid fibrils of human amylin, J. Mol. Biol. 348, 247-252.
30. Schmittschmitt, J. P., and Schotz, J. M. (2003) The role of protein stability, solubility, and net charge in amyloid fibril formation, Protein Sci. 12, 2378-2378.
31. Westermark, P., Li, Z. C., Westermark, G. T., Leckstrom, A., and Steiner, D. F. (1996) Effects of β-cell granule components on human islet amyloid polypeptide fibril formation, FEBS Lett. 379, 203-206.
32. Janciauskiene, S., Eriksson, S., Carlemalm, E., and Ahren, B. (1997) β-Cell granule peptides affect human islet amyloid polypeptide (IAPP) fibril formation in vitro, Biochem. Biophys. Res. Commun. 236, 580-585.
33. Jaikaran, E. T. A. S., Nilsson, M. R., and Clark, A. (2004) Pancreatic β-cell granule peptides form heteromolecular complexes which inhibit islet amyloid polypeptide fibril formation, Biochem. J. 377, 709-716.
34. Larson, J. L., and Miranker, A. D. (2004) The mechanism of insulin action on islet amyloid polypeptide fiber formation, J. Mol. Biol. 335, 221-231.